Crinetics Pharmaceuticals

About:

Crinetics is a clinical-stage pharmaceutical company that develops therapies for people with rare endocrine diseases.

Website: http://www.crinetics.com

Twitter/X: crinetics

Top Investors: OrbiMed, RA Capital Management, Invus, Perceptive Advisors, National Institutes of Health

Description:

Crinetics Pharmaceuticals discovers and develops novel therapeutics targeting peptide hormone receptors for the treatment of endocrine-related diseases and cancers. Their programs are derived from internal discovery efforts and use objective hormonal biomarker endpoints for preclinical and clinical studies to reduce both the risk and cost to achieve meaningful clinical data. Crinetics is seeking motivated partners to help advance Their programs to become commercially successful products.